Glycoprotein in Immunotherapy Response and Efficacy Prediction of Lung Cancer

Clinical trial NCT06730503 · RECRUITING

Trial details

NCT number: NCT06730503
Sponsor: Shanghai Chest Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Non Small Cell Lung Cancer

Start date: 2023-10-01
Primary completion: 2027-10-31
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.